A Prospective Dose Finding Study of Iscador Infusion

Clinical trial NCT04376931 · UNKNOWN

Trial details

NCT number: NCT04376931
Sponsor: HaEmek Medical Center, Israel
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2020-12-01
Primary completion: 2022-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.